Avenue Therapeutics Stock Quote ATXI - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Avenue Therapeutics Inc (ATXI) Quote

Avenue Therapeutics Inc (ATXI)

3.95

-0.05

(-1.25%)

At close: May 13 4:00PM

Delayed by 15 minutes

3.8533

-0.1467

( -3.67% )

After Hours: 5:53PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

3.8533

Bid

3.92

Ask

4.00

Volume

50,646

3.80 Day's Range 3.99

3.80 52 Week Range 93.75

Market Cap

Previous Close

4.00

Open

3.86

Last Trade

Last Trade Time

18:26:40

Financial Volume

$ 198,303

VWAP

3.9155

Average Volume (3m)

1,517,910

Shares Outstanding

13,247,622

Dividend Yield

-

PE Ratio

-5.06

Earnings Per Share (EPS)

-0.78

Revenue

-

Net Profit

-10.38M

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.avenuetx.com

Headquarters

Dover, Delaware, USA

Founded

1970

Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXI. The last closing price for Avenue Therapeutics was $4. Over the last year, Avenue Therapeutics shares have traded in a share price range of $ 3.80 to $ 93.75.

Avenue Therapeutics currently has 13,247,622 shares outstanding. The market capitalization of Avenue Therapeutics is $52.46 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -5.06.

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

MIAMI, April 29, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

Avenue Therapeutics Announces Reverse Stock Split

MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - - Presented positive BAER-101 preclinical...

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.8267	-17.6645299145	4.68	5.97	3.8	304136	4.22453971	CS
4	-6.5717	-63.0378896882	10.425	10.5	3.8	1561884	7.93601306	CS
12	-6.7517	-63.6652522395	10.605	15	3.8	1517910	10.58285408	CS
26	-12.8942	-76.9917898194	16.7475	26.4675	3.8	3981779	17.27052828	CS
52	-77.1467	-95.2428395062	81	93.75	3.8	2033535	18.06600384	CS
156	-4732.3967	-99.9186423859	4736.25	5833.125	3.8	1821130	388.85266926	CS
260	-5002.3967	-99.9230302122	5006.25	14130	3.8	1147053	731.41559529	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FPAYFlexShopper Inc	$ 1.33 (20.57%)	41.02k
FFIEFaraday Future Intelligent Electric Inc	$ 0.0712 (16.72%)	16.67M
VXRTVaxart Inc	$ 0.94 (14.63%)	452.42k
HROWHarrow Inc	$ 13.80 (14.33%)	65.96k
HYZNHyzon Motors Inc	$ 0.609 (12.74%)	356.91k
AUGXAugmedix Inc	$ 1.31 (-44.02%)	628.1k
AKYAAkoya BioSciences Inc	$ 2.84 (-31.07%)	50.07k
NTBLNotable Labs Ltd	$ 1.00 (-16.32%)	2.17k
NOTVInotiv Inc	$ 3.64 (-12.71%)	82.32k
BZFDBuzzFeed Inc	$ 1.86 (-12.26%)	92.67k
FFIEFaraday Future Intelligent Electric Inc	$ 0.0712 (16.72%)	16.67M
BIOLBiolase Inc	$ 0.1699 (-6.08%)	5.9M
LIFEaTyr Pharma Inc	$ 1.74 (2.35%)	4.5M
SQQQProShares UltraPro Short QQQ	$ 10.57 (0.19%)	2.67M
TRIPTripAdvisor Inc	$ 18.60 (-0.21%)	1.97M

Disquisition

Disquisition 2 weeks ago

INCOMPREHENSIBLE DUMPING

jelaco

jelaco 3 months ago

When is the Nas min compliance hearing.. anyone hear anything on that? Also, when's the r/s coming?

Animas

Animas 3 months ago

yea I flipped twice and loss twice.

DeafTrader2

DeafTrader2 3 months ago

I flipped it . No longer holding this ticker .

Animas

Animas 3 months ago

Notice of Effectiveness: New Five Year Low .113
R/S Coming Soon, to Stay Alive.

heyitsmeagain

heyitsmeagain 3 months ago

81vette

81vette 3 months ago

Todays email to me from ATXI,approved increase of outstanding to 200m(from 75m) also warrants issued .30(also reduced previous to exercise at .30)reason was they only had 161k cash left(ran out of $) debt is now $191m

glenn1919

glenn1919 4 months ago

ATXI..............................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783

DeafTrader2

DeafTrader2 4 months ago

Chart is improving ... Have bottomed out ..

YUUUPPPP

DeafTrader2

DeafTrader2 4 months ago

Wow ! ... What Happened Back Then ? Curious

DeafTrader2

DeafTrader2 4 months ago

IV Tramadol itself is a huge profit but are there other competitors that sell this drug ?

DeafTrader2

DeafTrader2 4 months ago

Is this stock a good buy right now ? 200M o/s

81vette

81vette 4 months ago

Filing states,approved raising o/s to 200M from 75M

81vette

81vette 4 months ago

I lost on first try to play,waiting for a bullish sign to try again (maybe,lose more) volume fading out is bad also

81vette

81vette 4 months ago

Buyout is best for shareholders short term with a big run and done

👍️ 1 💯 1 ☝️ 1

DeafTrader2

DeafTrader2 4 months ago

Is buy out a good thing for this ticker ?

DeafTrader2

DeafTrader2 4 months ago

Bottomed Out ... Shoulda, coulda, woulda ..... ?

RAlbert

RAlbert 4 months ago

Why so? What am I missing here?

DeafTrader2

DeafTrader2 4 months ago

Pendant northward ... sqeeze as FK

DeafTrader2

DeafTrader2 4 months ago

I am pissed that I FLIPPED THIS Today .l.. STUPID

81vette

81vette 4 months ago

Money raise warrants,ends tomorrow,ppl loading up,accumulation continues

🏁 1 👍️ 1 💯 1 ☝️ 1

DeafTrader2

DeafTrader2 4 months ago

this plane crashing back to this level ...

TheFinalCD

TheFinalCD 4 months ago

atxi .18's

get em while they're hot

LOL

Sunset Kid

Sunset Kid 4 months ago

Current O/S is 30M per dilution tracker. 90% were sold to investors in Nov and Jan. @ .30/share. Those transactions have provided $10M to the company for 2024 operating budget. https://dilutiontracker.com/app/search/ATXI

Sunset Kid

Sunset Kid 4 months ago

They sold 16.5 million shares (warrants) @ .30 for $5M. Funding for 2024 in place with less than 20M outstanding. This surge means something good is coming, imo. This is on everyones radar now. Let's squeeze the shorts to over a buck this week.

Sunset Kid

Sunset Kid 4 months ago

ATXI is #1 weekly and monthly gainer under a buck. Float has traded multipble times last week. Lets rock their world.

glenn1919

glenn1919 4 months ago

ATXI...........................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783

Sauerkraut

Sauerkraut 4 months ago

Yes. Worked out well. Now sell @.30 and stopp @.15.
Glty

TheFinalCD

TheFinalCD 4 months ago

correction .1981 avg

im tired

good weekend all

TheFinalCD

TheFinalCD 4 months ago

good call I had 20k bid @ .1625 it stops .1632 :/

MFalgoz

I bought 10k @ .2216 & 10K .175

holding 20k avg .2081

wonder if it tests .15 again?

may wait to see before I add more

38 to 18 what a shitshow

RAlbert

RAlbert 4 months ago

The warrants exercising at little over 30 cents is a good sign when compared with current share price. It is a steal to buy in at .185

DeafTrader2

DeafTrader2 4 months ago

Will add position Monday and Tuesday

81vette

81vette 4 months ago

Tripled my position with .185s,run started 17ish yesterday

👍️ 1 💯 1 ☝️ 1

DeafTrader2

DeafTrader2 4 months ago

Its a F.U. message from CEO ... !!!

DeafTrader2

DeafTrader2 4 months ago

Avenue Therapeutics Shares Drop 42% After Warrants Exercised

81vette

81vette 4 months ago

Ppl saying dilution,it’s warrants 20-50k orders,could run out (15m issued) before 9th (I wanted to say soon,but that’s just the greed/devil on my shoulder lol)

81vette

81vette 4 months ago

Pr states “could be strategic partnership” bring on a big name pharma and that 1.55 will be pffft (could be why only raising 5m,make partner pay the 50m for study and phase 4-5 to market,or sell it for 300m,lots of speculation on many ppls minds,confidence to me would be insider’s buying,that might create big run up to the 1.55

trendzone

trendzone 4 months ago

Not in the stock price,but if someone keeps averaging down from much higher levels too many times,and the stock keeps tanking, they could find themselves in a situation of being down that much on the amount of money they originally invested.

TheFinalCD

TheFinalCD 4 months ago

at least we are doing better than IVP

what a falling knife that was

81vette

81vette 4 months ago

$1.55 issued exercise,reduced price is .3006,closing on 9th

TheFinalCD

TheFinalCD 4 months ago

VWAP .2317

todays news didnt help https://www.globenewswire.com/news-release/2024/01/05/2804696/0/en/Avenue-Therapeutics-Enters-into-Warrant-Exercise-Transactions-for-5-0-Million-in-Proceeds.html

Triple nickle

Triple nickle 4 months ago

Yup in it avg’ing down thought it would go .18 but not happening

Sauerkraut

Sauerkraut 4 months ago

TheFinalCD

TheFinalCD 4 months ago

how is anything down more than -100%

please tell us LL

Message in reply to:
If you were compared to a stock, you would be considered a toxic diluted OTC that's down over 300% from its highs.

Sauerkraut

Sauerkraut 4 months ago

Closing the Gap

TheFinalCD

TheFinalCD 4 months ago

where you at with atxi

you still in, cut bait, coming back??

trickle nickle @ .48 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173562791

Message in reply to:
I tap it to keep it moving but to answer your question worst .28 I don’t think we’re done just yet this is the first day of three

TheFinalCD

TheFinalCD 4 months ago

sure just do the same when you see me on a board but not posting

Message in reply to:
I missed it,was busy with other things,thanks for the heads up,appreciated !!

TheFinalCD

TheFinalCD 4 months ago

filled more .21's will it hold???

TheFinalCD

TheFinalCD 4 months ago

I sold 4AM this morn the broker alert woke me up...

exited .28's

was so tired this morning after waking up 4am i missed the 9:15 drop to .20

but just re-started a position .226

with bids lower just incase

81vette

81vette 4 months ago

Just bought some.23s on the reversal,30% discount today

Avenue Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions